Steven Vogl, MD
Basic profileSteven Vogl is an Oncology physician affiliated with Montefiore Medical Center. OpenAlex indexes 77 publications with 2,053 citations (h-index 24).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- TAIHO ONCOLOGY, INC.Program year20241 payment$21
- Lilly USA, LLCProgram year20241 payment$20
- AstraZeneca Pharmaceuticals LPProgram year20235 payments$110
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
43.1%Statin13.1%Pravastatin Sodium32%Rosuvastatin Calcium29%Atorvastatin Calcium21%Simvastatin18%Part D<11 patientsBeta blocker9.5%Metoprolol Succinate46%Bisoprolol Fumarate29%Metoprolol Tartrate26%Part D<11 patients+ 4 more classes in this area
Metabolism & gastrointestinal
24.7%Potassium supplement6%Klor-Con M2051%Potassium Chloride49%Part D<11 patientsProton pump inhibitor4.3%Omeprazole100%Part D<11 patients+ 6 more classes in this area
Cancer & immunology
18.9%Aromatase Inhibitor7.2%Anastrozole100%Part D≥12 patientsCytochrome P450 17A1 Inhibitor5%Abiraterone Acetate100%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 1985–1986 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Adjuvant ovarian suppression for resected breast cancer: 2017 critical assessment
Breast Cancer Research and Treatment
2017 - High-Dose Megestrol Acetate in the Treatment of Patients With Ovarian Cancer Who Have Undergone Previous Treatment
American Journal of Clinical Oncology
1998
Similar KOLs
Other experts from the same institution or the same specialty.
Luigi Di Biase, MD
Montefiore Medical Center
Lawrence Brandt, MD
Montefiore Medical Center
Robert Michler, MD
Montefiore Medical Center
Sheryl Haut, MD
Montefiore Medical Center
Carl June, MD
University of Pennsylvania
Stuart Orkin, MD
Harvard Medical School
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”